Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engaging an Unstably Housed Population with Low-Barrier Buprenorphine Treatment at a Syringe Services Program: Lessons Learned from Seattle, Washington
Julia E. Hood, Caleb J. Banta‐Green, Jeffrey S. Duchin, et al.
Substance Abuse (2019) Vol. 41, Iss. 3, pp. 356-364
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

The Impact of COVID-19 on Syringe Services Programs in the United States
Sara N. Glick, Stephanie M. Prohaska, Paul LaKosky, et al.
AIDS and Behavior (2020) Vol. 24, Iss. 9, pp. 2466-2468
Open Access | Times Cited: 149
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Nora D. Volkow, Carlos Blanco
World Psychiatry (2023) Vol. 22, Iss. 2, pp. 203-229
Open Access | Times Cited: 114
Association of safer smoking supply distribution with participant encounters and naloxone distribution from syringe services programs: Findings from the National Survey of Syringe Services Programs in the United States
Esther O. Chung, Sheila V. Patel, Lynn D. Wenger, et al.
Drug and Alcohol Dependence Reports (2025) Vol. 14, pp. 100317-100317
Open Access | Times Cited: 2
The first five years of implementing Missouri's medication first approach to opioid use disorder treatment: Plateaus, regressions, and underbellies of progress
Rachel P. Winograd, Brandon Park, Bridget Coffey, et al.
Journal of Substance Use and Addiction Treatment (2025) Vol. 170, pp. 209622-209622
Open Access | Times Cited: 1
Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs—United States, 2016–2019: Perspectives on Recent Experience and Lessons Learned
Sheryl Lyss, Kate Buchacz, R. Paul McClung, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. Supplement_5, pp. S239-S249
Open Access | Times Cited: 91
Opioid use disorder treatment for people experiencing homelessness: A scoping review
Matthew F. McLaughlin, Rick Li, Nicolás Domínguez Carrero, et al.
Drug and Alcohol Dependence (2021) Vol. 224, pp. 108717-108717
Open Access | Times Cited: 55
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020
Czarina N. Behrends, Xinlin Lu, Grace Corry, et al.
Drug and Alcohol Dependence (2022) Vol. 232, pp. 109323-109323
Open Access | Times Cited: 40
Increasing Heroin‐Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs
Sara N. Glick, Kathryn S. Klein, Joe Tinsley, et al.
American Journal on Addictions (2020) Vol. 30, Iss. 2, pp. 183-191
Open Access | Times Cited: 63
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review
Madeline C. Frost, Hannah Lampert, Judith I. Tsui, et al.
Addiction Science & Clinical Practice (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 52
Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises
Lynn D. Wenger, Alex H. Kral, Ricky N. Bluthenthal, et al.
Translational research (2021) Vol. 234, pp. 159-173
Open Access | Times Cited: 42
PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure
Suzan M. Walters, David Frank, Brent Van Ham, et al.
AIDS and Behavior (2021) Vol. 26, Iss. 4, pp. 1308-1320
Open Access | Times Cited: 40
A Neuropharmacological Model to Explain Buprenorphine Induction Challenges
Mark K. Greenwald, Andrew A. Herring, Jeanmarie Perrone, et al.
Annals of Emergency Medicine (2022) Vol. 80, Iss. 6, pp. 509-524
Closed Access | Times Cited: 36
Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago
Sarah Messmer, Abigail T. Elmes, Antonio D. Jimenez, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 150, pp. 209054-209054
Open Access | Times Cited: 16
Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore’s Experience
Omeid Heidari, Diane Meyer, Kelly Lowensen, et al.
Health Affairs (2024) Vol. 43, Iss. 6, pp. 883-891
Closed Access | Times Cited: 5
Harm Reduction as a Complex Adaptive System: Results from a Qualitative Structural Analysis of Services Accessed by Young Heroin Users in Mauritius
Gareth White, Susan E. Luczak, Christiana Noestlinger
Youth (2025) Vol. 5, Iss. 1, pp. 10-10
Open Access
Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
Madeline C. Frost, Elsa W. Sweek, Elizabeth J. Austin, et al.
AIDS and Behavior (2021) Vol. 26, Iss. 1, pp. 57-68
Open Access | Times Cited: 39
Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review
Stephanie K. Rubel, Matthew Eisenstat, Jessica Wolff, et al.
Substance Use & Misuse (2023) Vol. 58, Iss. 5, pp. 685-697
Open Access | Times Cited: 14
Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study
Edward Suarez, Tyler S. Bartholomew, Marina Plesons, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 733-743
Open Access | Times Cited: 13
Identification and Management of Opioid Use Disorder in Primary Care: an Update
Joseph H. Donroe, Elenore P. Bhatraju, Judith I. Tsui, et al.
Current Psychiatry Reports (2020) Vol. 22, Iss. 5
Closed Access | Times Cited: 32
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes
Andrea Jakubowski, Brianna L. Norton, Benjamin T. Hayes, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 4, pp. 447-453
Open Access | Times Cited: 31
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Barrot H. Lambdin, David Kan, Alex H. Kral
Substance Abuse Treatment Prevention and Policy (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 21
Vaccination barriers and opportunities at syringe services programs in the United States, June–August 2021—A cross-sectional survey
Martha P. Montgomery, Yuna Zhong, Emma Roberts, et al.
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109540-109540
Closed Access | Times Cited: 19
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature
Andrea Jakubowski, Sabrina Fowler, Aaron D. Fox
Addiction Science & Clinical Practice (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness
Danielle R. Fine, Elizabeth Lewis, Karen Weinstock, et al.
JAMA Network Open (2021) Vol. 4, Iss. 3, pp. e210477-e210477
Open Access | Times Cited: 25
Harm Reduction Principles in a Street Medicine Program: A Qualitative Study
Jessica Frankeberger, Kelly Gagnon, Jim Withers, et al.
Culture Medicine and Psychiatry (2022) Vol. 47, Iss. 4, pp. 1005-1021
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top